These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18235967)
1. Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection. Barreto AM; Takei K; E C S; Bellesa MA; Salles NA; Barreto CC; Nishiya AS; Chamone DF Braz J Med Biol Res; 2008 Feb; 41(2):126-34. PubMed ID: 18235967 [TBL] [Abstract][Full Text] [Related]
2. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]. Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O; Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783 [TBL] [Abstract][Full Text] [Related]
3. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay. Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818 [TBL] [Abstract][Full Text] [Related]
4. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors. Pereira FM; Zarife MA; Reis EA; G Reis M Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731 [TBL] [Abstract][Full Text] [Related]
5. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection. Bossi V; Galli C J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753 [TBL] [Abstract][Full Text] [Related]
6. Signal to cut-off (S/CO) ratio and detection of HCV genotype 1 by real-time PCR one-step method: is there any direct relationship? Albertoni G; Arnoni CP; Araújo PR; Carvalho FO; Barreto JA Braz J Infect Dis; 2010; 14(2):147-52. PubMed ID: 20563440 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection. Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937 [TBL] [Abstract][Full Text] [Related]
8. Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay. Lai KK; Jin M; Yuan S; Larson MF; Dominitz JA; Bankson DD Clin Chem; 2011 Jul; 57(7):1050-6. PubMed ID: 21566071 [TBL] [Abstract][Full Text] [Related]
9. [Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection]. Payan C; Raimbert A; Fouchard-Hubert I; Kouyoumdjian S; Lunel-Fabiani F Ann Biol Clin (Paris); 2003; 61(3):311-7. PubMed ID: 12805008 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus seroconversion by a third generation ELISA screening test in blood donors. Atrah HI; Ahmed MM J Clin Pathol; 1996 Mar; 49(3):254-5. PubMed ID: 8675740 [TBL] [Abstract][Full Text] [Related]
11. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Pawlotsky JM; Lonjon I; Hezode C; Raynard B; Darthuy F; Remire J; Soussy CJ; Dhumeaux D Hepatology; 1998 Jun; 27(6):1700-2. PubMed ID: 9620345 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a supplemental assay for the diagnosis of hepatitis C virus infections. Rihn B; Hussenet F; Detry MB; Catelle A; Faou AL Int J Infect Dis; 2000; 4(1):42-5. PubMed ID: 10689214 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of a modified version of the ARCHITECT Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus. Echevarría JM; Avellón A; Jonas G; Hausmann M; Vockel A; Kapprell HP J Clin Virol; 2006 Apr; 35(4):368-72. PubMed ID: 16406797 [TBL] [Abstract][Full Text] [Related]
14. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?]. Sayan M; Meriç M; Mutlu B; Celebi S; Willke A Mikrobiyol Bul; 2006; 40(1-2):81-4. PubMed ID: 16775961 [TBL] [Abstract][Full Text] [Related]
15. Anti-HCV immunoblot indeterminate results in blood donors: non-specific reactivity or past exposure to HCV? Kiely P; Styles C Vox Sang; 2017 Aug; 112(6):542-548. PubMed ID: 28850195 [TBL] [Abstract][Full Text] [Related]
16. Reflex threshold of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for hepatitis C virus infection. Pan J; Li X; He G; Yuan S; Feng P; Zhang X; Qiu Y J Infect Dev Ctries; 2016 Sep; 10(9):1031-1034. PubMed ID: 27694738 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
18. Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective. Loubière S; Rotily M; Durand-Zaleski I; Costagliola D Vox Sang; 2001 May; 80(4):199-204. PubMed ID: 11438026 [TBL] [Abstract][Full Text] [Related]
19. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy]. Kusendová K; Gavorník P; Sabaka P; Sviteková K Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232 [TBL] [Abstract][Full Text] [Related]
20. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]